The Extended Transmembrane Orai1 N-terminal (ETON) Region Combines Binding Interface and Gate for Orai1 Activation by STIM1
Overview
Authors
Affiliations
STIM1 and Orai1 represent the two molecular key components of the Ca(2+) release-activated Ca(2+) channels. Their activation involves STIM1 C terminus coupling to both the N terminus and the C terminus of Orai. Here we focused on the extended transmembrane Orai1 N-terminal (ETON, aa73-90) region, conserved among the Orai family forming an elongated helix of TM1 as recently shown by x-ray crystallography. To identify "hot spot" residues in the ETON binding interface for STIM1 interaction, numerous Orai1 constructs with N-terminal truncations or point mutations within the ETON region were generated. N-terminal truncations of the first four residues of the ETON region or beyond completely abolished STIM1-dependent Orai1 function. Loss of Orai1 function resulted from neither an impairment of plasma membrane targeting nor pore damage, but from a disruption of STIM1 interaction. In a complementary approach, we monitored STIM1-Orai interaction via Orai1 V102A by determining restored Ca(2+) selectivity as a consequence of STIM1 coupling. Orai1 N-terminal truncations that led to a loss of function consistently failed to restore Ca(2+) selectivity of Orai1 V102A in the presence of STIM1, demonstrating impairment of STIM1 binding. Hence, the major portion of the ETON region (aa76-90) is essential for STIM1 binding and Orai1 activation. Mutagenesis within the ETON region revealed several hydrophobic and basic hot spot residues that appear to control STIM1 coupling to Orai1 in a concerted manner. Moreover, we identified two basic residues, which protrude into the elongated pore to redound to Orai1 gating. We suggest that several hot spot residues in the ETON region contribute in aggregate to the binding of STIM1, which in turn is coupled to a conformational reorientation of the gate.
TRP channels and breast cancer: the role of TRPs in the pathophysiological development.
Zhang Y, Yi Y, Shu Y, Ru X, He S Front Mol Biosci. 2025; 12:1528663.
PMID: 40078961 PMC: 11896876. DOI: 10.3389/fmolb.2025.1528663.
Water in peripheral TM-interfaces of Orai1-channels triggers pore opening.
Hopl V, Tiffner A, Wutscher A, Sallinger M, Grabmayr H, Prantl M Commun Biol. 2024; 7(1):1522.
PMID: 39550503 PMC: 11569263. DOI: 10.1038/s42003-024-07174-6.
Photocrosslinking-induced CRAC channel-like Orai1 activation independent of STIM1.
Maltan L, Weiss S, Najjar H, Leopold M, Lindinger S, Hoglinger C Nat Commun. 2023; 14(1):1286.
PMID: 36890174 PMC: 9995687. DOI: 10.1038/s41467-023-36458-4.
Celastrol inhibits store operated calcium entry and suppresses psoriasis.
Yuan X, Tang B, Chen Y, Zhou L, Deng J, Han L Front Pharmacol. 2023; 14:1111798.
PMID: 36817139 PMC: 9928759. DOI: 10.3389/fphar.2023.1111798.
A pathogenic human Orai1 mutation unmasks STIM1-independent rapid inactivation of Orai1 channels.
Yeung P, Yamashita M, Prakriya M Elife. 2023; 12.
PMID: 36806330 PMC: 9991058. DOI: 10.7554/eLife.82281.